Guided TherapeuticsGTHP -7.69%18 Days Payable is 0.00 as of Mar. 2026. GuruFocus rates GTHP with a GF Score™ of 18/100. The stock has 4 warning signs investors should review. Among 795 Medical Devices & Instruments companies, Guided Therapeutics ranks better than 98.49% on this metric.
The historical rank and industry rank for Guided Therapeutics's Days Payable or its related term are showing as below:
GTHP'
s Days Payable Range Over the Past 10 Years
Min: 1637.69 Med: 12368.99 Max: 151584.5
Current: 4359.41
During the past 13 years, Guided Therapeutics's highest Days Payable was 151584.50. The lowest was 1637.69. And the median was 12368.99.
GTHP's Days Payable is ranked better than 98.49% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 67.87
vs GTHP: 4359.41
Guided Therapeutics's Days Payable
stayed the same
from Mar. 2025 (0.00) to Mar. 2026 (0.00).
stayed the same
Guided Therapeutics Days Payable Related Terms
Guided Therapeutics Days Payable Historical Data
* Premium members only.
The historical data trend for Guided Therapeutics's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Guided Therapeutics's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Guided Therapeutics Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Guided Therapeutics's Days Payable distribution charts can be found below:
* The bar in red indicates where Guided Therapeutics's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Guided Therapeutics's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Guided Therapeutics (GTHP) has a Days Payable of 0.00 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Guided Therapeutics and its competitors. Over the past decade, Guided Therapeutics' Days Payable has ranged from 1,637.69 to 151,584.50. According to the industry distribution chart, Guided Therapeutics ranks #12 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 1.5%.
Is Guided Therapeutics' Days Payable too high?
Guided Therapeutics' current Days Payable is 0.00. Over the past 10 years, this metric has ranged from a low of 1,637.69 to a high of 151,584.50. Based on the distribution chart, Guided Therapeutics ranks #12 out of 795 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Guided Therapeutics has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Guided Therapeutics' Days Payable compare to LFWD and VNRX?
According to the Medical Devices & Instruments industry distribution chart, Guided Therapeutics ranks #12 out of 795 companies for Days Payable. This places Guided Therapeutics in the top 2% of its industry — outperforming the majority of peers. The industry median Days Payable is 67.87. Historically, Guided Therapeutics' own Days Payable has ranged from 1,637.69 to 151,584.50 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.87, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Guided Therapeutics and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Guided Therapeutics's current Days Payable is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guided Therapeutics stock overvalued right now?
Guided Therapeutics (GTHP) has a current Days Payable of 0.00. The current Days Payable is 0.00. Guided Therapeutics' overall GF Score™ is 18/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Guided Therapeutics (GTHP), the current Days Payable is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Guided Therapeutics Inc is a medical technology company. It is engaged in developing medical devices that have the potential to improve healthcare. Its primary focus is the sales and marketing of its LuViva Advanced Cervical Scan non-invasive cervical cancer detection device and the extension of its cancer detection technology into other cancers, including esophageal. The company generates revenue from the sale of medical devices.
18GF Score
Get the complete analysis for GTHP
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GTHP has been successfully added to your 
